(Q63573040)
Statements
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice)- Phase 2 Subprotocol of Vemurafenib in Patients With Tumors Harboring Braf V600 Mutations (English)
0 references
24 July 2017
0 references
31 December 2023
0 references
49
0 references
12 month
0 references
21 year
0 references